[TOP STORY] Compounded weight-loss drugs raise serious patient safety concerns

Loading player...
‘I think the main concern with compounded GLP-1s, is that they are not actually assessed or tested by the applicable regulators,’ says Charles Green, healthcare and pharmaceutical expert at Cliffe Dekker Hofmeyr.
15 May 8AM English South Africa Business News · Politics

Other recent episodes

Ratings upgrade on the cards after Moody’s thumbs-up

Why even the best turnaround plan might not be sufficient to deal with Joburg’s broken finances. A new survey shows financial stress affects mental health across generations. And big brand values surge by R232bn.
27 Oct 6AM 33 min